Regarding the microbiology and risk factors of hospital-acquired pneumonia (HAP), all of the following statements are TRUE EXCEPT:

Explanation

## Hospital-Acquired Pneumonia: Microbiology and Risk Stratification **Key Point:** While *Pseudomonas aeruginosa* is a critically important gram-negative pathogen in HAP — especially in patients with prolonged ICU stay and mechanical ventilation — it is **NOT** universally "the most common" gram-negative pathogen in HAP. Enterobacteriaceae (e.g., *Klebsiella pneumoniae*, *E. coli*, *Enterobacter* spp.) collectively represent the most prevalent gram-negative organisms in HAP across most epidemiological studies. Calling *Pseudomonas* "the most common gram-negative pathogen" is an overstatement that makes Option D the FALSE statement. ### Common Pathogens in HAP: Epidemiology | Pathogen | Frequency | Risk Factors | Mortality Impact | |----------|-----------|--------------|------------------| | *Enterobacteriaceae* (*Klebsiella*, *E. coli*, *Enterobacter*) | Most common gram-negatives overall | Aspiration, prior antibiotics, comorbidities | Moderate–High | | *Pseudomonas aeruginosa* | Major gram-negative, especially in late/ICU HAP | Prolonged ICU stay, mechanical ventilation, prior broad-spectrum antibiotics | High | | *Acinetobacter baumannii* | Common in ICU, multidrug-resistant | ICU stay > 5 days, mechanical ventilation | Very high | | *Staphylococcus aureus* (MSSA/MRSA) | Significant gram-positive | Prior antibiotic exposure, MRSA colonization, post-operative | High (MRSA) | **Why the other options are TRUE:** - **Option A (TRUE):** *Acinetobacter baumannii* is a well-recognized MDR gram-negative pathogen in ICU-acquired HAP with high mortality — consistent with Harrison's and ATS/IDSA HAP guidelines. - **Option B (TRUE):** MRSA is a recognized HAP pathogen; vancomycin and linezolid are the standard agents for MRSA coverage in HAP — this is textbook-correct per ATS/IDSA 2016 HAP guidelines. - **Option C (TRUE):** Early HAP (onset within 48–96 hours of admission) is typically caused by community-acquired organisms (*S. pneumoniae*, *H. influenzae*, MSSA) and carries a better prognosis than late HAP, which is dominated by resistant gram-negatives. **High-Yield:** *Pseudomonas aeruginosa* is a high-priority pathogen in HAP risk stratification (especially with structural lung disease, prior antibiotic use, prolonged hospitalization), but Enterobacteriaceae are collectively more prevalent. Labeling *Pseudomonas* as "the most common gram-negative" is factually inaccurate. **Clinical Pearl:** ATS/IDSA 2016 guidelines recommend *Pseudomonas* coverage in HAP patients with risk factors (prior IV antibiotics, structural lung disease, ICU admission), but this is risk-stratified — not because it is the single most common gram-negative pathogen. [cite: Harrison's Principles of Internal Medicine, 21e, Ch. 297; ATS/IDSA HAP/VAP Guidelines, AJRCCM 2016]